AEB 0.00% 0.9¢ affinity energy and health limited

Nutraceuticals Market Update

  1. 10 Posts.
    lightbulb Created with Sketch. 1
    The Global aquaculture market is set to rise rapidly between now and 2030. The global market for aquaculture is expected to reach USD 202.96 billion by 2020, Global aquaculture demand is expected to reach 80,400 kilo tons by 2020, growing at a CAGR of 2.0%. Aquaculture’s share in global supply will likely continue to expand to the point where capture fisheries and aquaculture will be contributing equal amounts by 2030, with the total projected fish supply to be 186 million tons in 2030.

    The demand for fishmeal and fish oil will likely become stronger, given the fast expansion of the global aquaculture and sluggishness of the global capture fisheries that supply their ingredients. During the 2015–30 period, prices in real terms are expected to rise by 90 percent for fishmeal and 70 percent for fish oil.

    Looking across regions, China will likely increasingly influence the global fish markets. According to the baseline model results, in 2030 China will account for 37 percent of total fish production (17 percent of capture production and 57 percent of aquaculture production), while accounting for 38 percent of global consumption of food fish. China omega 3 market
    size from infant formulas may register over USD 50 million at the end of forecast period.

    This will drive up the demand for omega 3 (EPA/DPA) fish oils as a source of feed in aquaculture. The global forecast for EPA/DHA (Omega 3) Ingredients Market share is anticipated to reach USD 4 billion by 2024. Shift in consumer focus towards nutrient based diet due to multiple health benefits should favor EPA/DHA ingredients market size. It is used to reduce cholesterol level, heart diseases and blood pressure level. Pharmaceutical applications may witness highest gains at above 5.5%. It is used to reduce cholesterol levels in the body which may further fuel product demand

    Alge.Tec (“ASX:AEB”) is strategically positioned to meet these demands with its high quality nutraceuticals production capacity at its Atlanta based facility. AEB is targeting significant revenue growth in the 2018 calendar year from sales of its FeedMe algae products in the North American aquarist market.
 
watchlist Created with Sketch. Add AEB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.